Prudential, Sino Biopharm among top stock picks for Hong Kong, Indonesia, Malaysia: UOBKH
UOB Kay Hian (UOBKH) updated its alpha picks for June, focusing on domestic catalysts and high-growth opportunities across Hong Kong, Indonesia and Malaysia, based on its report on Jun 5.
Here are its top picks in the three markets.
Hong Kong
Hong Kong's Hang Seng Index rebounded 5.3 per cent month on month in May following the 90-day tariff war truce that China and the US reached, UOBKH noted.
The agreement was to lower US tariffs on Chinese goods from 145 per cent to around 30 per cent, with reciprocal action by China on US goods.
'Nonetheless, geopolitical uncertainties and tariff war risks remain. Hence, we continue to favour domestic policy beneficiaries and defensive sectors that have been gaining traction in recent weeks,' it said.
A NEWSLETTER FOR YOU
Friday, 8.30 am Asean Business
Business insights centering on South-east Asia's fast-growing economies.
Sign Up
Sign Up
'May's economic data showed weakness and we opine that the (Chinese) government would accelerate support policy implementation in the near term,' its analysts said.
They have added Prudential and Sino Biopharm to its 'buy' list.
Analyst Kenny Lim maintained a 'buy' call on Prudential with a higher target price of HK$128, given that its new business profit rose 12 per cent year on year in Q1 2025. He expects the positive momentum to continue into H2, mainly due to margin improvement from product repricing actions and an improving product mix.
Analysts Carol Dou and Sunny Chen also maintained a 'buy' call on Sino Biopharm with a higher target price of HK$5.80.
This is largely due to the company's strong clinical progress with its oncology pipeline and innovative drugs which drove its 2024 revenue to 28.9 billion yuan (S$5.2 billion), up 10.2 per cent from the previous year. Its six newly approved drugs in 2024 are expected to hit double-digit revenue growth in 2025.
The bank maintained a 'buy' call on other Chinese stocks including Alibaba, China Resources Beer and Xiaomi.
Indonesia
UOBKH removed all of its previous alpha picks for Indonesia following notable performance shifts in May 2025.
It said that due to anticipation of monetary policy easing – which materialised when Bank Indonesia implemented a 25 basis point rate cut on May 21 – companies including Bank Central Asia and Bank BTN outperformed during the month.
Telco service company Erajaya Swasembada also delivered strong returns, supported by positive sentiments from the iPhone 16 launch event in April, increasing traction in the Chagee tea brand, and optimism ahead of the upcoming electric vehicle launch of XPeng.
Conversely, technology-related names such as GoTo and Buka underperformed, as investor attention turned towards beneficiaries of interest rate cuts and laggard sectors.
The Indonesian government introduced six stimulus initiatives aimed at boosting domestic consumption through June and July, including wage subsidies and public transport discounts.
These measures, combined with falling oil prices and a strengthening rupiah, are expected to improve sentiment in the consumer non-cyclical sector, which underperformed the Jakarta Stock Exchange Index by 5.3 per cent in May, the analysts said.
Looking ahead, UOBKH is shifting its focus towards consumer-related, 'safe-haven' and high-growth stocks.
Analyst Benyamin Mikael placed a 'buy' call on Central Omega Resources – with a raised target price of 570 rupiah and potential upside of 46.9 per cent – on the back of 'expected continued earnings momentum and higher nickel ore prices'.
Meanwhile, analyst Willinoy Sitorus put a 'buy' call on Cisarua Mountain Dairy, and raised its target price to 6,000 rupiah, with a potential upside of 29 per cent. He noted that it has seen strong consumer food sales, lower milk powder price and strengthening rupiah.
Other alpha picks include Aneka Tambang, with a target price of 3,300 rupiah, implying a slight potential downside of 0.6 per cent; Indofood CBP, with an upgraded target price of 13,800 rupiah, offering an upside potential of 27.8 per cent; and Sumber Alfaria Trijaya, with a target price of 3,400 rupiah, representing a 34.4 per cent upside from the closing price on Jun 2.
All were assigned a 'buy' rating by UOBKH.
Malaysia
The Bursa Malaysia KLC Index fell 2.1 per cent in May. Sector-wise, the biggest laggards were automobiles, which dropped 17 per cent, and consumer stocks, which fell 4.3 per cent, said UOBKH.
The strongest performers were construction stocks, which jumped 11.6 per cent, property-related stocks, which climbed 3.2 per cent, and building materials.
Other notable gainers included the port sector, which rose 6.5 per cent, and selected subsectors within technology, analysts noted. On the downside, glove manufacturers posted a 11.3 per cent loss.
UOBKH's May Malaysian portfolio outperformed the benchmark, delivering an average positive return of 7.2 per cent. Only RHB Bank posted negative returns, dropping 3.3 per cent in the month.
Looking ahead, UOBKH is shifting focus towards domestically driven catalysts, citing potential headwinds for exporters from forex volatility and a seasonal 'summer lull', coinciding with the end of the US 90-day tariff pause and signs of a US slowdown.
A major domestic catalyst is the kick-off of the Penang LRT project, benefiting construction players such as Gamuda and Hume Cement.
Other key drivers included continued strong earnings from Duopharma and NorthEast, and the expected broad adoption of MyDigital ID Superapp, developed by MyEG-Mimos – particularly among subsidy recipients and travellers.
UOBKH has taken a less defensive stance in its latest alpha picks, adding Hume Cement and removing Time.com, citing limited near-term catalysts for IOI Properties and NationGate, and reduced need for defensives following the market pullback.
Analyst Ku Wei Xiang maintained a 'buy' call on Hume Cement, with a target price of RM4.05, implying 54.5 per cent upside from the closing price on Jun 9.
He noted that the commencement of the Penang LRT project would translate to around RM2 billion (S$607.1 million) to RM2.6 billion in cement demand, assuming a RM13 billion construction cost of the project.
Other alpha picks included Duopharma, with an unchanged target price of RM1.46; Eco World, with an unchanged target price of RM2.37; Gamuda, with a raised target price of RM5.55; IJM Corporation, with a higher target price of RM3.15; and NorthEast, with an unchanged target price of RM0.47.
All were assigned a 'buy' rating by the research house.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
24 minutes ago
- Straits Times
China can buy Nvidia H20 chips again. But it's not all good news
Sign up now: Get ST's newsletters delivered to your inbox The Cyberspace Administration of China on July 31 flagged concerns about possible 'backdoor' security risks associated with the H20 chips, which American chipmaker Nvidia has denied. – Two weeks after Nvidia's chief executive Jensen Huang mounted a charm offensive to court the Chinese market, the American chip giant found itself once again the centre of attention in Beijing – and not in a good way. 'Nvidia, how can I trust you?' So read the headline of a commentary published by the People's Daily, the communist party's mouthpiece, a day after Chinese regulators summoned on July 31 the company's representatives over what they deemed 'serious security issues' related to its chips. The processor in question, known as the H20, was until recently the most advanced chip that Nvidia could sell to China under US restrictions. Washington effectively banned their exports in April amid an escalating trade war, but said in July that it would allow sales to resume. Some US officials touted the easing of export controls as a negotiating chip in ongoing trade talks with Beijing. But this apparent concession, analysts say, is not necessarily all good news for China. 'The reversal of the H20 ban offers short-term relief for China's artificial intelligence (AI) industry,' said Mr Charlie Dai, a vice president and principal analyst at advisory firm Forrester Research. 'On the other hand, it could slow domestic chipset adoption and impact the pace of technology self-reliance (amid) ongoing geopolitical frictions.' A taste for Nvidia China has been advocating the use of homegrown chips by its companies as part of a broader push for self-reliance, including in key technologies such as AI. Top stories Swipe. Select. Stay informed. Singapore LTA, Singapore bus operators reviewing Malaysia's request to start services from JB at 4am Singapore Despite bag checks and warnings, young partygoers continue to vape in clubs in Singapore Singapore President Tharman meets migrant workers who saved driver of car that fell into sinkhole Singapore Now flying solo, Acres CEO Kalaivanan Balakrishnan presses ahead with wildlife rescue efforts Opinion The charm – and drawbacks – of living in a time warp in Singapore Business UMS Integration becomes first SGX company with secondary listing in Malaysia Singapore Ong Beng Seng to plead guilty on Aug 4, more than 2 years after trip to Qatar with Iswaran Business Decoupling to save on tax? You may lose right to property if ties go awry Despite this, many Chinese AI firms – in particular private tech giants – are said to still prefer using Nvidia's H20s to train and run their models, even though the chips are not Nvidia's most powerful. After the US announced a lifting of its export ban, news agency Reuters reported that Chinese companies were scrambling to buy the H20s, citing sources. It also said that Nvidia had placed fresh orders for 300,000 chipsets from its contract manufacturer amid strong Chinese demand. 'The general sense is that Chinese customers, especially Bytedance, Baidu, Tencent and Alibaba, still prefer Nvidia's solutions, whether it's H20 or whatever comes next,' said Mr Ray Wang, research director for semiconductors, supply chain and emerging tech at advisory firm The Futurum Group. Nvidia's edge over its Chinese rivals – which 'continue to improve' – is manifold for now, he explained. Its hardware has larger memory bandwidth, making it better for inference tasks, or the application of trained AI models that makes them useful in the real world. The company also has a stronger software platform with which to program the chips, as well as more capable networking technology to harness the combined performance of hundreds and thousands of processors, Mr Wang said. Importantly, he added, Chinese firms' rivalry with Huawei – seen as the biggest domestic rival to Nvidia on the chip front – also fuels their preference for the American chipmaker. Huawei has a sprawling business empire that boasts not just chipsets, but also extends to cloud computing and AI model development. This puts them in direct competition with the other tech giants. Mr Wang said: 'So if you're Alibaba or Tencent, do you want to source your most important computing resources from Huawei?' The push for self-reliance Nvidia's current advantages notwithstanding, analysts say that China will simultaneously double down on growing its domestic chip ecosystem – a goal that could be helped by regulators' recent scrutiny of the American firm. The Cyberspace Administration of China had on July 31 flagged concerns about possible 'backdoor' security risks associated with the H20 chips, which Nvidia has denied . A People's Daily commentary released on social media the next day sketched out possible 'nightmare' scenarios associated with such risks, such as electric cars suddenly losing power on the highway. It asked the company to provide proof of the chips' security to alleviate users' worries. The regulators' move 'will likely cause Chinese tech firms to temporarily curb adoption (of the H20) due to fears of potential vulnerabilities and regulatory uncertainty, despite strong underlying demand,' said Mr Dai of Forrester Research. He added that even as companies' continued reliance on Nvidia's superior AI capabilities may sustain some purchases of its chips, he expected firms to simultaneously also accelerate shifts towards domestic alternatives. Mr Su Lian Jye, chief analyst at technology research firm Omdia, said that Chinese firms in recent years had already been buying more homegrown chipsets or developing their own amid sharpening geopolitical tensions. These include China's three major telcos, banks, cloud service providers, and various other state-linked companies, he said. Tech giants including Baidu and Alibaba are also developing their own chips. In recent weeks, following news that Nvidia would once again be allowed to ship H20s to China, local firms have spoken up about strengthening support for homegrown chipmakers. On July 25, AI start-up StepFun, a model developer, announced an 'ecosystem innovation alliance' with several domestic chip companies including Huawei, Cambricon, Moore Threads and MetaX, news outlet Caixin reported. The same day, StepFun released a large language model that was developed with the properties of domestic chips in mind, the report also said. Separately, co-founder of cyber-security company Qihoo 360 Zhou Hongyi said on July 23 that his company had turned to procuring domestic chips, and that its recent purchases had all been of Huawei products, news outlet Yicai reported. The company, which has also branched into AI, is on the US' entity list, which restricts access to American technology. Mr Zhou acknowledged that there was a 'gap' between Chinese chips and Nvidia's, but stressed the need to use domestic processors anyway, in comments that were videoed and uploaded to social media. 'If you don't use them, the gap will always be there,' he said. 'The more (you) use them, the more they will improve.'
Straits Times
4 hours ago
- Straits Times
China and Russia start joint drills in Sea of Japan
Sign up now: Get ST's newsletters delivered to your inbox The 'Joint Sea-2025' exercises kicked off in waters near the Russian port of Vladivostok and would last for three days. BEIJING - China and Russia began joint naval drills in the Sea of Japan, also known as East Sea, on Aug 3 as they seek to reinforce their partnership and counterbalance what they see as a US-led global order. Alongside economic and political ties, Moscow and Beijing have strengthened their military cooperation in recent years, and their relations have deepened since Russia invaded Ukraine in February 2022. The 'Joint Sea-2025' exercises kicked off in waters near the Russian port of Vladivostok and would last for three days, China's defence ministry said in a statement on Aug 3. The two sides will hold 'submarine rescue, joint anti-submarine, air defence and anti-missile operations, and maritime combat'. Four Chinese vessels, including guided-missile destroyers Shaoxing and Urumqi, are participating in the exercises alongside Russian ships, the ministry said. After the drills, the two countries will conduct naval patrols in 'relevant waters of the Pacific'. China and Russia have carried out annual drills for several years, with the 'Joint Sea' exercises beginning in 2012. Top stories Swipe. Select. Stay informed. Singapore LTA, Singapore bus operators reviewing Malaysia's request to start services from JB at 4am Singapore Despite bag checks and warnings, young partygoers continue to vape in clubs in Singapore Singapore Ong Beng Seng to plead guilty on Aug 4, more than 2 years after trip to Qatar with Iswaran Singapore Now flying solo, Acres CEO Kalaivanan Balakrishnan presses ahead with wildlife rescue efforts Opinion The charm – and drawbacks – of living in a time warp in Singapore Business Decoupling to save on tax? You may lose right to property if ties go awry Singapore NDP 2025: Veteran Red Lion says each leap 'feels like 5km run' Singapore Lessons learnt from Singapore's love-hate relationship with e-scooters 2024's drills were held along China's southern coast. The Chinese defence ministry said on Aug 1 that 2025's exercises were aimed at 'further deepening the comprehensive strategic partnership' of the two countries. China has never denounced Russia's more than three-year war nor called for it to withdraw its troops, and many of Ukraine's allies, including the United States, believe that Beijing has provided support to Moscow. China insists it is a neutral party, regularly calling for an end to the fighting while also accusing Western countries of prolonging the conflict by arming Ukraine. AFP
Business Times
4 hours ago
- Business Times
South-East Asian firms test Hong Kong waters amid IPO surge
[SINGAPORE] South-east Asian companies have mostly sat out Hong Kong's 2025 listing boom , but a cautious revival may be under way with four more initial public offerings (IPOs) from the region in the pipeline, according to the Hong Kong Stock Exchange (HKEX). Johnson Chui, HKEX's head of issuer services, told The Business Times that four South-east Asian companies are preparing to list, though he did not name them. If these plans proceed, they would mark the highest annual number of South-east Asian IPOs in Hong Kong since 2020, signalling a slow rebound after a prolonged slump. The pandemic and unfavourable macroeconomic conditions drove a steep decline in regional interest, with just three South-east Asian IPOs recorded between 2021 and 2024, compared with more than 65 in the five years prior. The new listings could include that of Singapore-headquartered apparel retailer Shein. In July, it filed for an IPO on HKEX after its plans to debut in New York and London were stymied by regulatory pressures . Chui told BT that the exchange continues to seek opportunities from the south. 'HKEX is deeply committed to strengthening ties with Asean markets,' he said, noting that the bourse frequently conducts roadshows in the region. A NEWSLETTER FOR YOU Friday, 8.30 am Asean Business Business insights centering on South-east Asia's fast-growing economies. Sign Up Sign Up In the first half of 2025, three regional companies listed on HKEX: Indonesia-based Nanshan Aluminium, Singapore biotech firm Mirxes , and Thai coconut water-maker IFBH . They accounted for 7 per cent of the bourse's 43 IPOs so far this year, as overall activity rebounded sharply. In H1, IPOs and cross-listings on HKEX totalled 210 deals, raising US$49.2 billion – more than nine times the US$5.3 billion raised a year ago, based on data from S&P Global Market Intelligence. The 43 IPOs in H1 2025 marked a sharp jump from the 29 in the same period in 2024, and the 27 in H1 2023. 'Most of the success we've seen in the capital markets in Hong Kong has been from Chinese companies,' said Jon Withaar, head of Asia special situations at Pictet Asset Management. Much of HKEX's fundraising surge has stemmed from the 175 dual-listed companies that also trade on the mainland's A-shares market. For these firms, Hong Kong's deep capital markets and currency fungibility provide greater flexibility. Mainland markets The prospect of expanding into the Chinese market has prompted some South-east Asian companies to make the leap. Listing on HKEX could lead to greater recognition among investors across Greater China, or the leverage of brand familiarity for fundraising. Thailand's IFBH, whose coconut water brand IF commands a significant market share in China, cited desires to grow its business in the wider region following its Hong Kong debut in June. ' Most of the success we've seen in the capital markets in Hong Kong has been from Chinese companies. ' — Jon Withaar, head of Asia special situations at Pictet Asset Management In addition, Hong Kong's efforts to attract listings from key sectors could draw the attention of Greater China companies. Specialist technology firms in China have flocked to HKEX as the bourse offered pathways to lessen compliance burdens for applications within the sector. This may be why cancer diagnostics startup Mirxes chose HKEX over the Singapore Exchange (SGX) for its IPO in May, citing better valuations and a more savvy investor pool. This is despite the company's links with Singapore government bodies such as the Agency for Science, Technology and Research, and the Economic Development Board. Homecoming bias Admittedly, South-east Asia's own IPO market has been relatively quiet, with fundraising reaching a decade-long low in 2024 . Fresh listings in H1 2025 have also underperformed compared to the year before, a Deloitte report noted. Local exchanges have remained more attractive than HKEX for new listings, with fundraising flexibility and policy incentives laying the foundations for domestic players to access funds. 'Major Asean members have their own currencies and domestic stock markets to fund business growth,' a Bloomberg Intelligence report noted in July. 'The bias remains for South-east Asian companies to list on their local exchanges in 'homecomings',' said Pictet's Withaar, pointing out that government-linked investment companies and sovereign wealth funds in countries such as Malaysia, Indonesia and Singapore often support large listings in the region. Such government involvement is expected to persist in South-east Asia's capital markets. 'Companies increasingly favour local exchanges over international ones due to regulatory support and growing domestic investor interest,' Stephen Bates, partner and head of deal advisory at KPMG in Singapore, told BT last month. As a result, little of Hong Kong's listing activity in the last few years has come from South-east Asia, Withaar noted. 'These are markets for Chinese and Hong Kong investors, who can understand Chinese businesses much more than (those) in Thailand, Vietnam or Malaysia.' Cross-listings Notably, HKEX may still find additional reach in dual-primary or secondary-listed companies which already trade on Asean exchanges. The bourse may already have signalled a strategic shift, which HKEX chief executive Bonnie Chan hinted at in a June interview: 'I am now beginning to realise that our sweet spot may not be private companies.' 'We're now more focused on companies which are actually already listed on another market, but might have outgrown their domestic market,' she added. Since 2022, international issuers have been included in HKEX's Stock Connect programme, which allows mainland Chinese investors to trade and settle shares listed on Hong Kong boards. Access to these investors may be why companies such as Malaysia-listed Capital A, the parent company of low-cost carrier AirAsia, is now seeking a secondary listing on the Hong Kong bourse. ' I am now beginning to realise that our sweet spot may not be private companies. We're now more focused on companies which are actually already listed on another market, but might have outgrown their domestic market. ' — Bonnie Chan, HKEX chief executive As part of efforts to woo more South-east Asian firms, HKEX has included several exchanges from the region in its list of recognised stock exchanges – allowing companies already listed on these boards to pursue secondary listings in Hong Kong without being subject to additional regulatory requirements. The bourse added the Indonesia Stock Exchange to this list in 2023, and the Stock Exchange of Thailand in March this year. The list already includes SGX, but not Malaysia's or Vietnam's main stock exchanges. Seventeen companies from South-east Asia –- including 16 from Singapore and one from Malaysia – are currently trading on both HKEX and their domestic bourses, Bloomberg data indicated. Even so, access to additional fundraising is far from a given for South-east Asian companies. SGX-listed real estate player LHN discovered this as it voluntarily delisted from the Hong Kong bourse in July, citing compliance costs and low trading volumes. Liquidity concerns, the company's board said, had limited its opportunities to conduct secondary equity fundraising on HKEX. Pictet's Withaar also warned that dealmaking in Hong Kong still suffers from deep cyclicality, where listing booms come and go. 'Just 18 months ago, there were miniscule levels of activity in the Hong Kong capital markets,' he said. 'This is unlike the US, which has a very deep and liquid market. There is always a steady stream of capital markets transactions.' When it comes to overseas listings, Wall Street exchanges Nasdaq and the New York Stock Exchange remain the gold standard for foreign companies due to better liquidity and valuations, he added. Compared to the three South-east Asian listings on HKEX, six regional companies have already gone public on Nasdaq in 2025, all of which are headquartered in Singapore.
